Soy isoflavones and their bone protective effects

Inflammopharmacology

Volumn 16, Issue 5, 2008, Pages 213-215

  Zhang, Y ^a   Chen, W F ^b,c   Lai, W P ^c   Wong, M S ^c  

^a UNIVERSITY OF CHICAGO   (United States)

^b QINGDAO UNIVERSITY   (China)

^c HONG KONG POLYTECHNIC UNIVERSITY   (Hong Kong)

Author keywords

Bone health; Breast cancer; Genistein; Osteoblastic functions; Postmenopausal osteoporosis; Soy isoflavones

Indexed keywords

ALKALINE PHOSPHATASE; ESTROGEN RECEPTOR; GENISTEIN; ISOFLAVONE DERIVATIVE; NOVASOY; OSTEOCLAST DIFFERENTIATION FACTOR; OSTEOPROTEGERIN; SOY EXTRACT; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BONE DENSITY; BONE DISEASE; BREAST CANCER; CANCER INHIBITION; CELL GROWTH; CONTROLLED STUDY; CYTOARCHITECTURE; DIETARY INTAKE; IN VIVO STUDY; MOUSE; NONHUMAN; OSTEOBLAST; OSTEOLYSIS; OVARIECTOMY; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; SHORT SURVEY; SOYBEAN;

ANIMALS; BONE DENSITY; BREAST NEOPLASMS; GENISTEIN; HUMANS; OSTEOBLASTS; RANK LIGAND; RNA, MESSENGER;

EID: 58149117931     PISSN: 09254692     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10787-008-8018-7     Document Type: Short Survey

References (22)

1. Allred, C. D., Allred. K. F., Ju.,Y. H., Goeppinger, T. S., Doerge, D. R. and Helferich, W. G. (2004). Soy processing influences growth of estrogen-dependent breast cancer tumors. Carcinogenesis 25(9), 1649-57.
2. Atmaca, A., Kleerekoper, M., Bayraktar, M. and Kucuk, O. (2008) Soy isoflavones in the management of postmenopausal osteoporosis, Menopause 15(4), 1-10.
3. Brink, E., Coxam, V., Robins, S., Wahala, K., Cassidy, A., and Branca, F. (2008). Long-term consumption of isoflavone-enriched foods does not affect bone mineral density, bone metabolism, or hormonal status in early postmenopausal women: a randomized, double-blind, placebo controlled study. Am. J. Clin. Nutr. 87, 761-70.
4. Chen, W. F. and Wong, M. S. (2004). Genistein enhances insulin-like growth factor signaling pathway in human breast cancer (MCF-7) cells. J Clin Endo Metab 89(5), 2351-9.
5. Chen, W. F. and Wong, M. S. (2006). Genistein modulates the effects of parathyroid hormone in human osteoblastic SaOS-2 cells. Brit. J. Nutr. 95, 1039-47.
6. Chen, W. F., Gao, Q. G. and Wong, M. S. (2007). Mechanism involved in genistein activation of insulin-like growth factor 1 receptor expression in human breast cancer cells. Brit J Nutr 98, 1120-5.
7. Chen, W. F., Huang, M. H., Tzang, C. H., Yang, M. and Wong, M. S. (2003). Inhibitory actions of genistein in human breast cancer (MCF-7) cells, Biochim Biophys Acta. 1638(2), 187-96.
8. Chen, Y. M., Ho, S., Lam, S. H. et al. (2003). Soy isoflavones have a favorable effect on bone loss in Chinese postmenopausal women with lower bone mass: a double-blind, randomized, controlled trial. J Clin. Endocrinol. Metab. 88, 4740-7.
9. Cooper, C., Westlake, S., Harvey, N., Javaid, K., Dennison, E. and Hanson, M. (2006). Review: developmental origins of osteoporotic fracture, Osteoporos. Int. 17, 337-47.
10. Cummings, S. R. and Melton, L. J. (2002). Epidemiology and outcomes of osteoporotic fractures, Lancet 359, 1761-67.
11. Davison, S. and Davis, S. R. (2003). Hormone replacement therapy: current controversies, Clin Endo 58, 249-61.
12. Dennison, E., Cole, Z., Cooper, C. (2005). Diagnosis and epidemiology of osteoporosis, Curr. Opin. Rheumatol. 17, 456-61.
13. Frankenfeld, C., Lampe, J. W., Shannon, J. et al. (2004). Frequency of soy food consumption and serum isoflavone concentrations among Chinese women in Shanghai, Public Health Nutr 7(6), 765-72.
14. Geller, S. E. and Studee, L. (2006). Soy and red clover for mid-life and aging, Climacteric 9(4), 245-63.
15. Hsieh, C. Y., Santoli, R. C., Haslam, S. Z. and Helferich, W. G. (1998). Estrogenic effects of genistein on the growth of estrogen receptor-positive human breast cancer (MCF-7) cells in vitro and in vivo. Cancer Res 58, 3833-8.
16. Lauderdale, D., Jacobsen, S. J., Furner, S. E., Levy, P. S., Brody, J. A. and Goldberg, J. (1997). Hip fracture incidence among elderly Asian-American populations. Am J Epidemiol 146, 502-9.
17. Marini, H., Minutoli, L., Polito, F. et al. (2007). Effects of the phytoestrogen genistein on bone metabolism in osteopenic postmenopausal women, Ann. Intern Med. 146, 839-47.
18. Mei, J., Yeung, S. S. C., Kung, A. W. C. (2001). High dietary phytoestrogen intake is associated with higher bone mineral density in postmenopausal but not premenopausal women. J Clin. Endocrinol. Metab. 86, 5217-21.
19. Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M. and Allan, J. D. (2002). Postmenopausal hormone replacement therapy: scientific review, JAMA. 288(7), 872-81.
20. Ross, P. D., Norimatsu, H., Davis, J. W., Yano, K., Wasnich, R. D., Fujiwara. S. et al. (1991). A comparison of hip fracture incidence among native Japanese, Japanese Americans, and American Caucasians. Am J Epidemiol 133, 801-9.
21. Weaver, C. M. and Cheong, J. M. K. (2005). Soy isoflavones and bone health: the relationship is still unclear, J. Nutr. 135, 1243-7.
22. Williamson, G. and Manach, C. (2005). Bioavailability and bioefficacy of polyphenols in humans. II. Review of 93 intervention studies, Am. J. Clin. Nutr. 81(suppl), 243S-55S.